December 10-13, 2011, San Diego, CA - Researchers from the Bing Center for WM attended the 53rd Annual ASH Meeting and Exposition. There they delivered 5 oral presentations including findings from the first whole genome sequencing project for WM, and continuing investigations into the MYD88 signaling pathway, and expression of Oct-2, Spi-B, and Id2/Id1.
Three posters were also presented, showcasing the latest research in the areas of bortezomib-containing regimens, MicroRNA studies, and a multicenter study of the MTOR inhibitor Everolimus (RAD001).
For more information about the American Society of Hematology (ASH) 54th annual meeting and exposition, please visit their website at http://www.hematology.org/Meetings/Annual-Meeting/
ASH 2011: Bing Center Oral Presentations
Click the hyperlink to download the abstract for the presentation
Guang Yang: Disruption of MYD88 Pathway Signaling Leads to Loss of Constitutive IRAK1, NF-κβ and JAK/STAT Signaling and Induces Apoptosis of Cells Expressing the MYD88 L265P Mutation in Waldenstrom’s Macroglobulinemia
ASH 2011: Bing Center Poster Presentations
Click the hyperlink to download the full-size poster as a PDF file